{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:36:00Z","timestamp":1789875360812,"version":"4.0.1"},"reference-count":198,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Neurodegenerative disorders such as Alzheimer\u2019s disease (AD) and malignant neoplasms are among the most prevalent age-associated diseases worldwide. Although cancer is characterized by uncontrolled proliferation, resistance to apoptosis, and metabolic reprogramming, AD and other neurodegenerative disorders such as Lewy body disease (LBD) including Parkinson\u2019s Disease (PD) and fronto-temporal lobar degeneration (FTLD) are defined by synaptic dysfunction, neuronal loss, neuroinflammation, and impaired proteostasis with misfolded protein aggregates. Despite these contrasting phenotypes, converging epidemiological and molecular data support an inverse relationship between cancer and neurodegenerative disorders, whereby a history of cancer is associated with reduced AD risk, whereas AD is linked to a lower incidence of multiple malignancies. These observations suggest that oncogenesis and neurodegeneration may represent divergent outcomes of shared biological processes dysregulated during aging. This conundrum likely reflects differential regulation of core cellular pathways governing cell survival, stress responses, metabolism, and genomic integrity but could also reflect the differential influence of aging pathways and secreted growth factors. Pro-survival and proliferative signaling pathways commonly activated in cancer, including PI3K\u2013AKT\u2013mTOR signaling, altered p53 function, enhanced DNA damage tolerance, and anabolic metabolism, are often impaired in AD, LBD and FTLD, where neurons exhibit heightened vulnerability to stress, mitochondrial dysfunction, defective autophagy, and activation of pro-apoptotic cascades. Conversely, tumor-suppressive mechanisms that restrain proliferation may protect against malignancy but increase susceptibility to degeneration in post-mitotic neurons. Aging-related processes such as cellular senescence, immune dysregulation, and loss of proteostasis may further exert divergent effects in oncogenesis and neurodegeneration. This review aims to clarify associations between specific cancer types and neurodegenerative disorders, examine shared and opposing selected molecular mechanisms linking specific cancers and neurodegeneration, and contextualize these relationships within broader aging pathways (e.g., cell senescence, proteostasis). By integrating epidemiological, mechanistic, and therapeutic perspectives, we highlight unifying biological principles and translational opportunities at the intersection of cancer, neurodegeneration, and aging.<\/jats:p>","DOI":"10.3390\/cells15131177","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:20Z","timestamp":1782722720000},"page":"1177","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emerging New Pathways in Malignant Neoplasms and Neurodegenerative Disorders: Perspectives for Therapeutics"],"prefix":"10.3390","volume":"15","author":[{"given":"Wolf","family":"Wrasidlo","sequence":"first","affiliation":[{"name":"Radiation Medicine and Applied Sciences Department, University of California, San Diego, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, University of California, San Diego, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"(2024). 2024 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement., 20, 3708\u20133821.","DOI":"10.1002\/alz.13809"},{"key":"ref_2","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer\u2019s disease: Synapse loss is the major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"39826","DOI":"10.31083\/JIN39826","article-title":"Proteostasis and Neuroinflammation in Alzheimer\u2019s Disease","volume":"24","author":"Potokiri","year":"2025","journal-title":"J. Integr. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1007\/s12035-023-03260-8","article-title":"Cancer and Alzheimer\u2019s Inverse Correlation: An Immunogenetic Analysis","volume":"60","author":"Bhardwaj","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"115327","DOI":"10.1016\/j.bbr.2024.115327","article-title":"Meta-analysis reveals an inverse relationship between Alzheimer\u2019s disease and cancer","volume":"478","author":"Zheng","year":"2025","journal-title":"Behav. Brain Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41380-020-0760-2","article-title":"Cancer and Alzheimer\u2019s disease inverse relationship: An age-associated diverging derailment of shared pathways","volume":"26","author":"Lanni","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wolfrum, P., Fietz, A., Schnichels, S., and Hurst, J. (2022). The function of p53 and its role in Alzheimer\u2019s and Parkinson\u2019s disease compared to age-related macular degeneration. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.1029473"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pan, J., Yao, Q., Wang, Y., Chang, S., Li, C., Wu, Y., Shen, J., and Yang, R. (2024). The role of PI3K signaling pathway in Alzheimer\u2019s disease. Front. Aging Neurosci., 16.","DOI":"10.3389\/fnagi.2024.1459025"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e14463","DOI":"10.1111\/cns.14463","article-title":"mTOR signaling and Alzheimer\u2019s disease: What we know and where we are?","volume":"30","author":"Davoody","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.24272\/j.issn.2095-8137.2023.294","article-title":"Targeting autophagy in Alzheimer\u2019s disease: Animal models and mechanisms","volume":"44","author":"Zhang","year":"2023","journal-title":"Zool. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e00525","DOI":"10.1016\/j.neurot.2025.e00525","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: Guiding the path to targeted therapies","volume":"22","author":"Liu","year":"2025","journal-title":"Neurotherapeutics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00439-023-02565-x","article-title":"Cellular senescence and neurodegeneration","volume":"142","author":"Holloway","year":"2023","journal-title":"Hum. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40035-025-00517-1","article-title":"Immunosenescence in aging and neurodegenerative diseases: Evidence, key hallmarks, and therapeutic implications","volume":"14","author":"Chen","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e210130","DOI":"10.1212\/WNL.0000000000210130","article-title":"Chemotherapy-Related Cognitive Impairment and Changes in Neural Network Dynamics: A Systematic Review","volume":"104","author":"Leskinen","year":"2025","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-clinpsy-050817-084903","article-title":"Cognitive Effects of Cancer and Cancer Treatments","volume":"14","author":"Ahles","year":"2018","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41467-025-56690-4","article-title":"Drug repurposing for Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"16","author":"Cummings","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acschemneuro.3c00531","article-title":"Aging Hallmarks and Progression and Age-Related Diseases: A Landscape View of Research Advancement","volume":"15","author":"Tenchov","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1002\/1878-0261.13302","article-title":"The role of aging in cancer","volume":"16","author":"Havas","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_23","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"101441","DOI":"10.1016\/j.disamonth.2022.101441","article-title":"Recent advances in Lewy body dementia: A comprehensive review","volume":"69","author":"Prasad","year":"2023","journal-title":"Dis. Mon."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/svn-2025-004048","article-title":"Updates on vascular dementia","volume":"10","author":"Ng","year":"2025","journal-title":"Stroke Vasc. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"eabb8255","DOI":"10.1126\/science.abb8255","article-title":"Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies","volume":"371","author":"Chang","year":"2021","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"fcae128","DOI":"10.1093\/braincomms\/fcae128","article-title":"The subcortical default mode network and Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"6","author":"Seoane","year":"2024","journal-title":"Brain Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e70483","DOI":"10.1002\/alz.70483","article-title":"Alzheimer\u2019s disease and its co-pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE epsilon4","volume":"21","author":"Gawor","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cger.2022.07.005","article-title":"Neuropathology of the Common Forms of Dementia","volume":"39","author":"Mehta","year":"2023","journal-title":"Clin. Geriatr. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1212\/WNL.0b013e31829c5ec1","article-title":"Inverse occurrence of cancer and Alzheimer disease: A population-based incidence study","volume":"81","author":"Musicco","year":"2013","journal-title":"Neurology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000356498","article-title":"Inverse and direct cancer comorbidity in people with central nervous system disorders: A meta-analysis of cancer incidence in 577,013 participants of 50 observational studies","volume":"83","author":"Valderas","year":"2014","journal-title":"Psychother. Psychosom."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"107190","DOI":"10.1016\/j.nbd.2025.107190","article-title":"Disentangling the inverse relationship between cancer and Alzheimer\u2019s or Parkinson\u2019s disease: A systematic review on Mendelian randomization studies","volume":"217","author":"Aung","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12967-023-04357-3","article-title":"Mendelian randomization and transcriptomic analysis reveal an inverse causal relationship between Alzheimer\u2019s disease and cancer","volume":"21","author":"Dong","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0b013e3181c91873","article-title":"Cancer linked to Alzheimer disease but not vascular dementia","volume":"74","author":"Roe","year":"2010","journal-title":"Neurology"},{"key":"ref_37","first-page":"45","article-title":"The association between Alzheimer\u2019s disease and cancer: Systematic review\u2014Meta-analysis","volume":"20","author":"Papageorgakopoulos","year":"2017","journal-title":"Hell. J. Nucl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e2025515","DOI":"10.1001\/jamanetworkopen.2020.25515","article-title":"Association Between Alzheimer Disease and Cancer with Evaluation of Study Biases: A Systematic Review and Meta-analysis","volume":"3","author":"Glymour","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3233\/JAD-220054","article-title":"The Relationship Between Prior Cancer Diagnosis and All-Cause Dementia Progression Among US Adults","volume":"88","author":"Fowler","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1038\/s41598-019-49795-6","article-title":"Evidence of a Causal Association Between Cancer and Alzheimer\u2019s Disease: A Mendelian Randomization Analysis","volume":"9","author":"Seddighi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1442","DOI":"10.1136\/bmj.e1442","article-title":"Inverse association between cancer and Alzheimer\u2019s disease: Results from the Framingham Heart Study","volume":"344","author":"Driver","year":"2012","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/WAD.0000000000000086","article-title":"Cancer and Dementia: It\u2019s Complicated","volume":"29","author":"Ganguli","year":"2015","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/EDE.0000000000001712","article-title":"Towards a Clearer Causal Question Underlying the Association Between Cancer and Dementia","volume":"35","author":"Schagen","year":"2024","journal-title":"Epidemiology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000341411","article-title":"Does Alzheimer\u2019s disease protect against cancers? A nationwide population-based study","volume":"40","author":"Ou","year":"2013","journal-title":"Neuroepidemiology"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kang, H.S., Kim, J.H., Lim, H., Kim, J.H., Noh, H.M., Choi, H.G., Min, K.W., Kim, N.Y., and Kwon, M.J. (2023). Alzheimer\u2019s Disease and Different Types of Cancer Likelihood: Unveiling Disparities and Potential Protective Effects in a Korean Cohort Study. Cancers, 15.","DOI":"10.3390\/cancers15184615"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00432-014-1773-5","article-title":"Alzheimer disease and cancer risk: A meta-analysis","volume":"141","author":"Shi","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10522-014-9523-2","article-title":"Inverse association between cancer and neurodegenerative disease: Review of the epidemiologic and biological evidence","volume":"15","author":"Driver","year":"2014","journal-title":"Biogerontology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/alz.12168","article-title":"The competing risk of death and selective survival cannot fully explain the inverse cancer-dementia association","volume":"16","author":"Ackley","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1212\/CON.0000000000001496","article-title":"Lewy Body Dementia","volume":"30","author":"Galvin","year":"2024","journal-title":"Continuum"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","article-title":"Investigating the genetic architecture of dementia with Lewy bodies: A two-stage genome-wide association study","volume":"17","author":"Guerreiro","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"fcae190","DOI":"10.1093\/braincomms\/fcae190","article-title":"Investigation of the genetic aetiology of Lewy body diseases with and without dementia","volume":"6","author":"Wu","year":"2024","journal-title":"Brain Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture","volume":"53","author":"Chia","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/alz.12814","article-title":"Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design","volume":"19","author":"Toledo","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3233\/JAD-220440","article-title":"Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old","volume":"90","author":"Lachner","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awac035","article-title":"Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer\u2019s-type neuropathology","volume":"145","author":"Karanth","year":"2022","journal-title":"Brain"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e046329","DOI":"10.1136\/bmjopen-2020-046329","article-title":"Parkinson\u2019s disease and cancer: A systematic review and meta-analysis of over 17 million participants","volume":"11","author":"Zhang","year":"2021","journal-title":"BMJ Open"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40035-015-0043-z","article-title":"The associations between Parkinson\u2019s disease and cancer: The plot thickens","volume":"4","author":"Feng","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1111\/ene.15069","article-title":"Cancer risk in Parkinson disease: An updated systematic review and meta-analysis","volume":"28","author":"Leong","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.18632\/aging.203932","article-title":"Parkinson\u2019s disease and cancer: A systematic review and meta-analysis on the influence of lifestyle habits, genetic variants, and gender","volume":"14","author":"Lee","year":"2022","journal-title":"Aging"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bjc.6602279","article-title":"Atypical cancer pattern in patients with Parkinson\u2019s disease","volume":"92","author":"Olsen","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/acschemneuro.9b00498","article-title":"Association between Parkinson\u2019s Disease and Risk of Cancer: A PRISMA-compliant Meta-analysis","volume":"10","author":"Zhang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41572-023-00447-0","article-title":"Frontotemporal lobar degeneration","volume":"9","author":"Grossman","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1474-4422(21)00341-0","article-title":"Advances and controversies in frontotemporal dementia: Diagnosis, biomarkers, and therapeutic considerations","volume":"21","author":"Boeve","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","article-title":"An update on genetic frontotemporal dementia","volume":"266","author":"Greaves","year":"2019","journal-title":"J. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/13543784.2024.2349286","article-title":"Frontotemporal dementia: From genetics to therapeutic approaches","volume":"33","author":"Buccellato","year":"2024","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13046-022-02352-y","article-title":"The role of TBK1 in cancer pathogenesis and anticancer immunity","volume":"41","author":"Runde","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/mus.26383","article-title":"Increased risk of melanoma in C9ORF72 repeat expansion carriers: A case-control study","volume":"59","author":"Almendra","year":"2019","journal-title":"Muscle Nerve"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3233\/JAD-170854","article-title":"Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration","volume":"62","author":"Katisko","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn3464","article-title":"Inverse cancer comorbidity: A serendipitous opportunity to gain insight into CNS disorders","volume":"14","author":"Rubenstein","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Plun-Favreau, H., Lewis, P.A., Hardy, J., Martins, L.M., and Wood, N.W. (2010). Cancer and neurodegeneration: Between the devil and the deep blue sea. PLoS Genet., 6.","DOI":"10.1371\/journal.pgen.1001257"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00018-019-03428-3","article-title":"Molecular crosstalk between cancer and neurodegenerative diseases","volume":"77","author":"Seo","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.gendis.2014.10.004","article-title":"Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance","volume":"2","author":"Denduluri","year":"2015","journal-title":"Genes. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12943-025-02336-4","article-title":"Cancer-nervous system crosstalk: From biological mechanism to therapeutic opportunities","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: A changing paradigm","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"113550","DOI":"10.1016\/j.isci.2025.113550","article-title":"Neurodegeneration rewires the tumor microenvironment via the neuro-immune-cancer axis","volume":"28","author":"Bautista","year":"2025","journal-title":"iScience"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cell.2025.12.020","article-title":"Peripheral cancer attenuates amyloid pathology in Alzheimer\u2019s disease via cystatin-c activation of TREM2","volume":"189","author":"Li","year":"2026","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Hu, C., Lin, M., Wang, C., and Zhang, S. (2025). Current Understanding of Protein Aggregation in Neurodegenerative Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262110568"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e14515","DOI":"10.1111\/cbdd.14515","article-title":"Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions","volume":"103","author":"Panwar","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e2314337121","DOI":"10.1073\/pnas.2314337121","article-title":"Inhibition of colorectal cancer in Alzheimer\u2019s disease is mediated by gut microbiota via induction of inflammatory tolerance","volume":"121","author":"Zhang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Blasco","year":"2013","journal-title":"Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","article-title":"Geroscience: Linking aging to chronic disease","volume":"159","author":"Kennedy","year":"2014","journal-title":"Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: An expanding universe","volume":"186","author":"Blasco","year":"2023","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the Light: The Growing Complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ceb.2008.02.005","article-title":"FoxO transcription factors in the maintenance of cellular homeostasis during aging","volume":"20","author":"Salih","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41467-017-02395-2","article-title":"Transcriptomic alterations during ageing reflect the shift from cancer to degenerative diseases in the elderly","volume":"9","author":"Schauble","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1568007053005127","article-title":"Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: Therapeutic implications","volume":"4","author":"Shacka","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/mutage\/geu045","article-title":"The expanding role of mTOR in cancer cell growth and proliferation","volume":"30","author":"Cargnello","year":"2015","journal-title":"Mutagenesis"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Ma, T., Hoeffer, C.A., Capetillo-Zarate, E., Yu, F., Wong, H., Lin, M.T., Tampellini, D., Klann, E., Blitzer, R.D., and Gouras, G.K. (2010). Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer\u2019s disease. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012845"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrn2124","article-title":"Cell cycle regulation in the postmitotic neuron: Oxymoron or new biology?","volume":"8","author":"Herrup","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0896-6273(03)00627-5","article-title":"Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles","volume":"40","author":"Cruz","year":"2003","journal-title":"Neuron"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrm2261","article-title":"The prolyl isomerase PIN1: A pivotal new twist in phosphorylation signalling and disease","volume":"8","author":"Lu","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Wang, L., Zhou, Y., Chen, D., and Lee, T.H. (2020). Peptidyl-Prolyl Cis\/Trans Isomerase Pin1 and Alzheimer\u2019s Disease. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00355"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Stewart, R., Sharma, S., Wu, T., Okuda, S., Xie, G., Zhou, X.Z., Shilton, B., and Lu, K.P. (2024). The role of the master cancer regulator Pin1 in the development and treatment of cancer. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1343938"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/21650","article-title":"The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein","volume":"399","author":"Lu","year":"1999","journal-title":"Nature"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Shafi, O. (2016). Inverse relationship between Alzheimer\u2019s disease and cancer, and other factors contributing to Alzheimer\u2019s disease: A systematic review. BMC Neurol., 16.","DOI":"10.1186\/s12883-016-0765-2"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/2159-8290.CD-16-0062","article-title":"Role of Telomeres and Telomerase in Aging and Cancer","volume":"6","author":"Shay","year":"2016","journal-title":"Cancer Discov."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3233\/JAD-2007-12109","article-title":"Unfolded p53: A potential biomarker for Alzheimer\u2019s disease","volume":"12","author":"Lanni","year":"2007","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/bs.acc.2024.04.002","article-title":"Proteostasis in neurodegenerative diseases","volume":"121","author":"Kinger","year":"2024","journal-title":"Adv. Clin. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Yang, H.M. (2025). Mitochondrial Dysfunction in Neurodegenerative Diseases. Cells, 14.","DOI":"10.3390\/cells14040276"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4000","article-title":"Cellular senescence in aging and age-related disease: From mechanisms to therapy","volume":"21","author":"Childs","year":"2015","journal-title":"Nat. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.gde.2010.10.005","article-title":"Cellular senescence: Putting the paradoxes in perspective","volume":"21","author":"Campisi","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/s12276-025-01480-7","article-title":"Hallmarks of cellular senescence: Biology, mechanisms, regulations","volume":"57","author":"Ajoolabady","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ccell.2025.05.015","article-title":"Senescence in cancer","volume":"43","author":"Colucci","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1474-9726.2012.00870.x","article-title":"Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response","volume":"11","author":"Jurk","year":"2012","journal-title":"Aging Cell"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Bhat, R., Crowe, E.P., Bitto, A., Moh, M., Katsetos, C.D., Garcia, F.U., Johnson, F.B., Trojanowski, J.Q., Sell, C., and Torres, C. (2012). Astrocyte senescence as a component of Alzheimer\u2019s disease. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045069"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","article-title":"Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline","volume":"562","author":"Bussian","year":"2018","journal-title":"Nature"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","article-title":"Senolytic therapy alleviates Abeta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model","volume":"22","author":"Zhang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","article-title":"The role of senescent cells in ageing","volume":"509","year":"2014","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3233\/JAD-230465","article-title":"Senescence Targeting Methods Impact Alzheimer\u2019s Disease Features in 3xTg Mice","volume":"97","author":"Ng","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","article-title":"The proteostasis network and its decline in ageing","volume":"20","author":"Hipp","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Chen, X.Q., Shen, T., Fang, S.J., Sun, X.M., Li, G.Y., and Li, Y.F. (2023). Protein homeostasis in aging and cancer. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1143532"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"BSR20254097","DOI":"10.1042\/BSR20254097","article-title":"Adaptive inter-tissue proteostasis networks in aging and neurodegeneration","volume":"46","author":"Ventura","year":"2026","journal-title":"Biosci. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2010.01.021","article-title":"Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E","volume":"17","author":"Hsieh","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-09-1970","article-title":"The role of Myc-induced protein synthesis in cancer","volume":"69","author":"Ruggero","year":"2009","journal-title":"Cancer Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.celrep.2017.03.010","article-title":"Enhanced Degradation of Misfolded Proteins Promotes Tumorigenesis","volume":"18","author":"Chen","year":"2017","journal-title":"Cell Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev-cellbio-100617-062636","article-title":"Intercellular Spread of Protein Aggregates in Neurodegenerative Disease","volume":"34","author":"Davis","year":"2018","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Barmaki, H., Nourazarian, A., and Khaki-Khatibi, F. (2023). Proteostasis and neurodegeneration: A closer look at autophagy in Alzheimer\u2019s disease. Front. Aging Neurosci., 15.","DOI":"10.3389\/fnagi.2023.1281338"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbamcr.2013.03.012","article-title":"Proteostasis and neurodegeneration: The roles of proteasomal degradation and autophagy","volume":"1843","author":"Tanaka","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00281-010-0213-0","article-title":"Autophagy and tumorigenesis","volume":"32","author":"Roy","year":"2010","journal-title":"Semin. Immunopathol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2045-3701-3-35","article-title":"Paradoxical roles of autophagy in different stages of tumorigenesis: Protector for normal or cancer cells","volume":"3","author":"Sun","year":"2013","journal-title":"Cell Biosci."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Masliah, E. (2025). Role of the Interplay Between Autophagy and Cell Senescence in the Pathogenesis and Therapeutics of Glioblastoma in the Aging Population. Cells, 14.","DOI":"10.3390\/cells14221764"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/alzrt217","article-title":"Autophagic\/lysosomal dysfunction in Alzheimer\u2019s disease","volume":"5","author":"Orr","year":"2013","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1172\/JCI73944","article-title":"Autophagy and neurodegeneration","volume":"125","author":"Frake","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2011.200","article-title":"Control of autophagy as a therapy for neurodegenerative disease","volume":"8","author":"Harris","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","article-title":"Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases","volume":"25","author":"Nixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular Senescence: Defining a Path Forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41556-018-0249-2","article-title":"The dynamic nature of senescence in cancer","volume":"21","author":"Lee","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"35","author":"Kilgore","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41583-020-0325-z","article-title":"Cellular senescence and Alzheimer disease: The egg and the chicken scenario","volume":"21","author":"Masliah","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tibs.2014.02.003","article-title":"FOXO transcription factors: Key regulators of cellular quality control","volume":"39","author":"Webb","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"856","DOI":"10.15252\/embj.201490784","article-title":"Autophagy in malignant transformation and cancer progression","volume":"34","author":"Galluzzi","year":"2015","journal-title":"EMBO J."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12035-013-8457-z","article-title":"Autophagy modulation for Alzheimer\u2019s disease therapy","volume":"48","author":"Zhu","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuron.2014.07.040","article-title":"Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits","volume":"83","author":"Tang","year":"2014","journal-title":"Neuron"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1748-1716.2007.01780.x","article-title":"FOXO transcription factors in ageing and cancer","volume":"192","author":"Greer","year":"2008","journal-title":"Acta Physiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1007\/s12035-021-02544-1","article-title":"Inverse Correlation Between Alzheimer\u2019s Disease and Cancer: Short Overview","volume":"58","author":"Zablocka","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ana.24628","article-title":"APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations","volume":"79","author":"Shinohara","year":"2016","journal-title":"Ann. Neurol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/CS20020329","article-title":"Apolipoprotein E gene polymorphism and colorectal cancer: Gender-specific modulation of risk and prognosis","volume":"104","author":"Watson","year":"2003","journal-title":"Clin. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","article-title":"Apolipoprotein e sets the stage: Response to injury triggers neuropathology","volume":"76","author":"Mahley","year":"2012","journal-title":"Neuron"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.92.11.4725","article-title":"Apolipoprotein E and Alzheimer disease","volume":"92","author":"Strittmatter","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3892\/ijo.2013.2057","article-title":"Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis","volume":"43","author":"Ifere","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00432-014-1634-2","article-title":"Association between apolipoprotein E genotype and cancer susceptibility: A meta-analysis","volume":"140","author":"Anand","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4143\/crt.2012.44.2.121","article-title":"Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis","volume":"44","author":"Saadat","year":"2012","journal-title":"Cancer Res. Treat."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mad.2008.06.002","article-title":"Antagonistic pleiotropy and p53","volume":"130","author":"Ungewitter","year":"2009","journal-title":"Mech. Ageing Dev."},{"key":"ref_154","first-page":"F115","article-title":"The p16INK4a\/CDKN2A tumor suppressor and its relatives","volume":"1378","author":"Ruas","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(03)00049-1","article-title":"An association study of the codon 72 polymorphism in the pro-apoptotic gene p53 and Alzheimer\u2019s disease","volume":"340","author":"Rosenmann","year":"2003","journal-title":"Neurosci. Lett."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"ENEURO.0124-15.2016","DOI":"10.1523\/ENEURO.0124-15.2016","article-title":"Neurons in Vulnerable Regions of the Alzheimer\u2019s Disease Brain Display Reduced ATM Signaling","volume":"3","author":"Shen","year":"2016","journal-title":"eNeuro"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"101243","DOI":"10.1016\/j.gim.2024.101243","article-title":"Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"27","author":"Pal","year":"2025","journal-title":"Genet. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13195-022-01101-9","article-title":"Genetically predicted telomere length and Alzheimer\u2019s disease endophenotypes: A Mendelian randomization study","volume":"14","author":"Operto","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Pungsrinont, T., Kallenbach, J., and Baniahmad, A. (2021). Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011088"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2174\/1570159X18666201111104509","article-title":"Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer\u2019s Disease","volume":"19","author":"Hashioka","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2174\/1570159X20666220114153308","article-title":"The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review","volume":"20","author":"Ikram","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.molmed.2022.07.003","article-title":"Cellular senescence in neuroinflammatory disease: New therapies for old cells?","volume":"28","author":"Nelke","year":"2022","journal-title":"Trends Mol. Med."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Stefani, C., Miricescu, D., Stanescu, S., Nica, R.I., Greabu, M., Totan, A.R., and Jinga, M. (2021). Growth Factors, PI3K\/AKT\/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910260"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1007\/s12035-024-04457-1","article-title":"Insulin-Like Growth Factor Signaling in Alzheimer\u2019s Disease: Pathophysiology and Therapeutic Strategies","volume":"62","author":"Miao","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e70361","DOI":"10.1111\/jnc.70361","article-title":"From Neuron-Centric to Glia-Centric: How Aging Glial Networks Drive Neurodegenerative Disease","volume":"170","author":"Hayashide","year":"2026","journal-title":"J. Neurochem."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic Signaling Pathways in The Cancer Genome Atlas","volume":"173","author":"Mina","year":"2018","journal-title":"Cell"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Potenza, R.L., Armida, M., and Popoli, P. (2024). Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031751"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13195-021-00831-6","article-title":"Anticancer drugs repurposed for Alzheimer\u2019s disease: A systematic review","volume":"13","author":"Ancidoni","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1016\/j.cell.2025.06.035","article-title":"Cell-type-directed network-correcting combination therapy for Alzheimer\u2019s disease","volume":"188","author":"Li","year":"2025","journal-title":"Cell"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1093\/hmg\/ddy143","article-title":"The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson\u2019s disease mouse model","volume":"27","author":"Lee","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-025-02179-x","article-title":"Protein kinases in neurodegenerative diseases: Current understandings and implications for drug discovery","volume":"10","author":"Wu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1093\/hmg\/ddt192","article-title":"Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of alpha-synuclein in Parkinson\u2019s disease models","volume":"22","author":"Hebron","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/emmm.201302771","article-title":"Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance","volume":"5","author":"Lonskaya","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00109-013-1112-3","article-title":"Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance","volume":"92","author":"Lonskaya","year":"2014","journal-title":"J. Mol. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuroscience.2015.07.070","article-title":"Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer\u2019s disease models","volume":"304","author":"Lonskaya","year":"2015","journal-title":"Neuroscience"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jns.2018.06.005","article-title":"Tau clearance improves astrocytic function and brain glutamate-glutamine cycle","volume":"391","author":"Hebron","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_178","first-page":"503","article-title":"Nilotinib Effects in Parkinson\u2019s disease and Dementia with Lewy bodies","volume":"6","author":"Pagan","year":"2016","journal-title":"J. Park. Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamaneurol.2020.4725","article-title":"Efficacy of Nilotinib in Patients with Moderately Advanced Parkinson Disease: A Randomized Clinical Trial","volume":"78","author":"Simuni","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/alzrt75","article-title":"Masitinib as an adjunct therapy for mild-to-moderate Alzheimer\u2019s disease: A randomised, placebo-controlled phase 2 trial","volume":"3","author":"Piette","year":"2011","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1523\/JNEUROSCI.0296-07.2007","article-title":"Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation","volume":"27","author":"Vecsey","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","article-title":"An epigenetic blockade of cognitive functions in the neurodegenerating brain","volume":"483","author":"Graff","year":"2012","journal-title":"Nature"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S1470-2045(14)70440-1","article-title":"Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: A multicentre, randomised, double-blind phase 3 trial","volume":"15","author":"Hungria","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer","volume":"75","author":"Campisi","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: The dark side of tumor suppression","volume":"5","author":"Coppe","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: The path to the clinic","volume":"28","author":"Chaib","year":"2022","journal-title":"Nat. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.tibs.2020.03.008","article-title":"Senescent Cells: Emerging Targets for Human Aging and Age-Related Diseases","volume":"45","author":"Song","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.celrep.2017.12.092","article-title":"Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson\u2019s Disease","volume":"22","author":"Chinta","year":"2018","journal-title":"Cell Rep."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"109419","DOI":"10.1016\/j.celrep.2021.109419","article-title":"Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer\u2019s disease and frontotemporal dementia","volume":"36","author":"Gaikwad","year":"2021","journal-title":"Cell Rep."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 heel of senescent cells: From transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/joim.13141","article-title":"Senolytic drugs: From discovery to translation","volume":"288","author":"Kirkland","year":"2020","journal-title":"J. Intern. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","volume":"354","author":"Talpaz","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e13296","DOI":"10.1111\/acel.13296","article-title":"Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice","volume":"20","author":"Ogrodnik","year":"2021","journal-title":"Aging Cell"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","article-title":"L1 drives IFN in senescent cells and promotes age-associated inflammation","volume":"566","author":"Ito","year":"2019","journal-title":"Nature"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"e70947","DOI":"10.1002\/cam4.70947","article-title":"Reactive Oxygen Species: From Tumorigenesis to Therapeutic Strategies in Cancer","volume":"14","author":"Attique","year":"2025","journal-title":"Cancer Med."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.clinthera.2015.08.026","article-title":"Response and Adverse Effects of Nilotinib in Imatinib-resistant Chronic Myeloid Leukemia Patients: Data From a Developing Country","volume":"37","author":"Hussain","year":"2015","journal-title":"Clin. Ther."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/13\/1177\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:21:04Z","timestamp":1782724864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/13\/1177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":198,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["cells15131177"],"URL":"https:\/\/doi.org\/10.3390\/cells15131177","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}